linagliptin and metformin hydrochloride
linagliptin and metformin hydrochloride · METFORMIN HYDROCHLORIDE 850 mg/1; LINAGLIPTIN 2.5 mg/1 · Tablet · Boehringer Ingelheim Pharma GmbH and Co. KG
NDC 12714-0802-01 · 40 TABLET in 1 DRUM · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of linagliptin and metformin hydrochloride (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Boehringer Ingelheim Pharma GmbH and Co. KG | METFORMIN HYDROCHLORIDE 850 mg/1; LINAGLIPTIN 2.5 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Boehringer Ingelheim Pharma GmbH and Co. KG | LINAGLIPTIN 2.5 mg/500mg | Jul 15, 2026 | Sep 2, 2026 |
| Boehringer Ingelheim Pharma GmbH and Co. KG | METFORMIN HYDROCHLORIDE 2.5 mg/1; LINAGLIPTIN 850 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Boehringer Ingelheim Pharma GmbH and Co. KG | LINAGLIPTIN 2.5 mg/1; METFORMIN HYDROCHLORIDE 850 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "linagliptin and metformin hydrochloride — NDC 12714-0802-01," retrieved September 3, 2026, https://drugdashboards.com/drug/12714080201.
Free to cite with attribution — see how the data is put together.